Drug shortage: Methylprednisolone Acetate Injection (DEPO-MEDROL, METHYLPREDNISOLONE ACETATE)
FDA lists 23 presentations as Current. Availability: Unavailable (4), Limited Availability (9), Available (10). Reason: Other; Demand increase for the drug. Companies: Pfizer Inc., Eugia US LLC, Amneal Pharmaceuticals, Par Health, USA LLC, Sagent Pharmaceuticals.
- Published by source
- 2021-12-15
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Pfizer Inc.
- Products
- Methylprednisolone Acetate Injection DEPO-MEDROL METHYLPREDNISOLONE ACETATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
- Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2021-12-15
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #890 | new | 2026-10-22 | 68fa998dc914…e6a24c | e4b87e58f80b…8fe735 |
| #1165 | update | 2026-10-23 | d6529d30fc2b…3bd06b | ba6fb8bb58a9…e093d2 |
Chain head: #1250 0c9a4a81d7d8…29590d